US$ 23.98
eli lilly glp-1 pill data is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating The FDA has approved a
Description
Lilly posted explosive 54% revenue growth powered by its GLP-1 obesity and diabetes drugs
Compare 10 GLP-1 agonist medications for weight loss including semaglutide and tirzepatide

The Trump administrations latest agreements with two major drugmakers to lower the cost of expensive weight loss and diabetes drugs, known as GLP-1s, are lik
A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

Cellular Energy & Stress*
Chinese companies that supplied U.S
